John D. Buchanan - 25 Jan 2022 Form 4 Insider Report for COMERICA INC /NEW/ (CMA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Jan 2022, 15:30:05 UTC
Prior SEC filing
25 Jan 2022
Next SEC filing
16 Apr 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jennifer S. Perry, on behalf of John D. Buchanan through Power of Attorney

Key filing fact

John D. Buchanan filed Form 4 for COMERICA INC /NEW/ (CMA) on 27 Jan 2022.

Key facts

  • This page summarizes John D. Buchanan's Form 4 filing for COMERICA INC /NEW/ (CMA).
  • 2 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 27 Jan 2022, 15:30.

Change

  • Previous filing in this sequence was filed on 25 Jan 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CMA transaction

Common Stock

Award

Transaction value
$0
Shares
+2,465
Change %
+5.9%
Price
$0.000000
Shares after
44,317
Date
25 Jan 2022
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CMA transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+3,050
Change %
Price
$0.000000
Shares after
3,050
Date
25 Jan 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,050
Exercise price
$92.58
Footnotes
F3
CMA holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,183
Date
25 Jan 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,183
Exercise price
$67.66
Footnotes
F3
CMA holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,285
Date
25 Jan 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,285
Exercise price
$95.25
Footnotes
F3
CMA holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,160
Date
25 Jan 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,160
Exercise price
$80.17
Footnotes
F3
CMA holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,705
Date
25 Jan 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,705
Exercise price
$63.15
Footnotes
F3
CMA holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,780
Date
25 Jan 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,780
Exercise price
$60.12
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Restricted stock units awarded under Issuer's Long-Term Incentive Plan.

Footnote F2

Includes shares acquired through employee stock plans and restricted stock units as of January 25, 2022.

Footnote F3

The options vest in four equal annual installments (based on the original grant amount) beginning on the date indicated in this column.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .